Prostate specific membrane antigen (PSMA), also known as folate hydrolase 1 (FOLH1) or glutamate carboxypeptidase II, is a type II transmembrane glycoprotein extensively studied in prostate cancers. This evidence concerns the gene FOLH1 and Familial prostate cancer.